Publication date: January 23, 2025

Introduction

The biotech industry thrives on innovation, with intellectual property (IP) serving as a cornerstone for protecting breakthroughs and attracting investment. Intellectual property rights (IPRs) provide legal mechanisms for safeguarding inventions, processes, and proprietary information, offering companies the tools to protect their most valuable assets.

 For biotechnology and pharmaceutical companies, IP is a critical driver of value, enabling financial rewards, market positioning, and investor confidence. While IPRs have a significant impact on all aspects of innovation, their relevance is particularly pronounced in downstream activities such as commercialization, manufacturing, and market access. Startups and established biotech firms alike must understand and leverage IPRs to ensure competitive advantages and long-term sustainability.

More